secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quotient Ltd (—)
CIK:        0001596946
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001193125-22-300271
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 1.01, 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quotient reaches restructuring deal: equity wiped out for no consideration, delisting from Nasdaq, 100 job cuts
--------------------------------------------------------------------------------

- All existing ordinary shares, options, warrants to be extinguished and cancelled for no consideration; delisting from Nasdaq planned.
- Senior secured noteholders to provide $10M bridge notes; exchange existing notes for new senior secured debt at discount.
- Convertible notes to be extinguished for no value; holders may purchase $28M in new common equity at 35% discount.
- Workforce reduction of ~100 positions as company shifts from transfusion diagnostics to autoimmune/allergy MosaiQ products.
- Company estimates $1.5-2.5M in pre-tax severance costs; majority paid in Q1-Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1596946/000119312522300271/0001193125-22-300271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1596946/000119312522300271/d431926d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-300271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer